Commit To Purchase Acadia Pharmaceuticals At $20, Earn 45.1% Annualized Using Options
October 19, 2016 at 11:40 AM EDT
Investors eyeing a purchase of Acadia Pharmaceuticals Inc (ACAD) shares, but tentative about paying the going market price of $23.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2017 put at the $20 strike, which has a bid at the time of this writing of $2.30..